Skip to content
Screener

Integra LifeSciences IART Rest of World — Total Revenues

Other geography segments

Asia Pacific
$48.7M+2.0%
Europe
$42.57M-0.1%

Similar metrics at other companies

ESP
ESPRCollaboration revenue — Total Revenues
$36.71M+22.0%
CME Group logo
CMEOther Revenue — Total Revenues
$115.6M+9.2%
Regis Corporation logo
RGSU.S. — Total Revenues
$48.55M+5.9%
News Corporation logo
NWSEurope — Total Revenues
$457.5M+7.0%
Xerox Holdings Corporation logo
XRXCanada — Total Revenues
$132M+22.2%
Xerox Holdings Corporation logo
XRXEurope — Total Revenues
$531M+21.2%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Dollars in thousandsThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$307,099$306,308$596,479$588,525
Europe42,57242,59482,53577,920
Asia Pacific48,69747,73293,90892,837
Rest of World20,39318,97137,75738,976
Total Revenues$418,761$415,605$810,679$798,258

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's rest of world — total revenues?
Integra LifeSciences (IART) reported rest of world — total revenues of $20.39M in Q2 2026.
How has Integra LifeSciences's rest of world — total revenues changed year-over-year?
Integra LifeSciences's rest of world — total revenues increased by 7.5% year-over-year, from $18.97M to $20.39M.
What is the long-term trend for Integra LifeSciences's rest of world — total revenues?
Over 3 years (2022 to 2025), Integra LifeSciences's rest of world — total revenues has grown at a -2.0% compound annual growth rate (CAGR), from $83.48M to $78.58M.
What does rest of world — total revenues mean?
This metric represents the total net sales generated from geographic regions outside of the company's primary domestic and major international markets. It captures the revenue contribution from emerging or secondary global territories, reflecting the company's geographic diversification and international market penetration strategy. Tracking this figure helps investors assess the scale of global operations and the success of expansion efforts in non-core geographic segments.

Ask your AI about Integra LifeSciences's rest of world — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude